65th ASH Annual Meeting and Exposition | Cromos Pharma

The premier event in classical and malignant hematology is headed to San Diego.

Meet Cromos Pharma

Vlad Bogin, MD, FACP, CEO | Cromos Pharma

Vlad Bogin, MD, FACP

CEO

vlad.bogin
@cromospharma.com

Stephanie Finnegan

Stephanie Finnegan

Chief Operating Officer

stephanie.finnegan
@cromospharma.com

CONTACT US

INQUIRY@CROMOSPHARMA.COM

Celebrating 20 years of success | Cromos Pharma

Celebrating 20 Years of Success with Cromos Pharma

New Cromos Pharma's office in Portugal

New Cromos Pharma’s Office in Portugal

Happy Labor Day 2024 | Cromos Pharma

Happy Labor Day 2024

Strategic Alliance: Syngene + Cromos Pharma

Expanding Horizons: “Syngene – Cromos Pharma” Alliance Transforms Clinical Research

Happy Bastille Day from Cromos Pharma

Happy Bastille Day from Cromos Pharma!

Happy Independence Day 2024 | Cromos Pharma

Happy Independence Day 2024

Partnership Between MAIA Biotechnology and Cromos Pharma

Successful Partnership Between MAIA Biotechnology and Cromos Pharma

Cromos Pharma’s Agnieszka Milewska-Kranc Leads the Way in EU’s Rare Disease Advocacy

Cromos Pharma’s Agnieszka Milewska-Kranc Leads the Way in EU’s Rare Disease Advocacy

Cromos Pharma is at the BIO International Convention 2024

We are at the BIO International Convention 2024

Cromos Pharma's Country Head Speaks at GCP Training Event in Istanbul

Cromos Pharma’s Country Head Speaks at GCP Training Event in Istanbul

Cromos Pharma's Strategic Meeting in Miami

Cromos Pharma’s Strategic Meeting in Miami

Happy Passover 2024 | Cromos Pharma

Happy Passover 2024

Cromos Pharma's Strategic Meeting in Warsaw

Cromos Pharma’s Strategic Meeting in Warsaw

Happy Easter 2024 | Cromos Pharma

Happy Easter 2024

FDA approves first direct-to-consumer glucose monitor | Cromos Pharma

Revolutionizing Diabetes Management: FDA Approves First Direct-to-Consumer Glucose Monitor